Nanobiotix S.A.
NBTX
$3.39
$0.24117.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.66M | -25.43M | -11.77M | -11.87M | -6.24M |
| Total Depreciation and Amortization | 444.00K | 457.90K | 421.90K | 425.50K | 414.50K |
| Total Amortization of Deferred Charges | 1.10K | 1.10K | 1.10K | 1.10K | 1.10K |
| Total Other Non-Cash Items | 15.82M | 16.31M | 1.62M | 1.63M | 6.13M |
| Change in Net Operating Assets | 1.08M | 1.12M | 6.59M | 6.65M | 2.28M |
| Cash from Operations | -7.31M | -7.54M | -3.14M | -3.17M | 2.58M |
| Capital Expenditure | -190.30K | -196.20K | -263.20K | -265.40K | -2.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.20K | -53.90K | -5.90K | -6.00K | -9.20K |
| Cash from Investing | -242.50K | -250.10K | -269.10K | -271.40K | -11.80K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -1.05M | -1.05M | -1.02M | -1.02M | -941.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 30.08M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -185.50K | -185.50K | -304.50K | -304.50K | -4.68M |
| Cash from Financing | -1.32M | -1.36M | -1.43M | -1.44M | 26.33M |
| Foreign Exchange rate Adjustments | 27.20K | 28.00K | 23.10K | 23.30K | -17.80K |
| Miscellaneous Cash Flow Adjustments | 500.00 | 600.00 | -- | -- | 500.00 |
| Net Change in Cash | -8.85M | -9.12M | -4.82M | -4.86M | 28.88M |